Compare BioNTech SE - ADR (BNTX) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs HCA Health Inc — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while HCA Health Inc trades at $410.11 (market cap $89.08B). The key difference: HCA Health Inc is far larger — about 3.8× BioNTech SE - ADR's market cap, and HCA Health Inc pays a 0.76% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | HCA | |
|---|---|---|
Market Cap | $23.31B | $89.08B |
Sector | Health | Health |
52-Week High | $119.34 | $545.13 |
52-Week Low | $83.89 | $361.32 |
Enterprise Value | $6.60B | $139.62B |
Dividend Yield | — | 0.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
